NOW FDA-APPROVED
ZIIHERA: The first and only dual HER2-targeted treatment for HER2-positive BTC
- ZIIHERA is a dual HER2-targeted bispecific antibody* used to treat adults previously treated for a type of bile duct (cholangiocarcinoma) or gallbladder cancer called biliary tract cancer (BTC) that is human epidermal growth factor receptor 2 (HER2)-positive (IHC 3+)
- ZIIHERA is approved based on response rate and how long the response lasted. Additional studies will further evaluate the benefit of ZIIHERA for this use
- It is not a chemotherapy; ZIIHERA is a dual bispecific antibody engineered to target HER2 on tumor cells
- ZIIHERA is for people who previously received treatment
*A bispecific antibody is able to target 2 cancer-causing proteins on a tumor cell.
To learn more, please see the full ZIIHERA Prescribing Information
WE'RE HERE TO SUPPORT YOU
JazzCares is committed to helping you get access to your ZIIHERA medication.
To help you get access to ZIIHERA, JazzCares Specialists are available to assist you with:
- Understanding your insurance coverage
- Other cost and coverage questions
- Referrals to other financial assistance for which you may be eligible
JazzCares is committed to helping you reduce your out-of-pocket costs for ZIIHERA
- Savings Card—eligible, commercially insured patients can pay as little as $10 for their ZIIHERA medication, subject to an annual maximum
Patient Assistance Program, if you are eligible
- Financial and other eligibility criteria may apply
You can learn more about JazzCares support offerings by calling 1-833-533-JAZZ (5299) Monday–Friday between 8 AM and 8 PM ET or visiting JazzCares.com
Insurance coverage and plans may vary. The JazzCares Program at Jazz Pharmaceuticals provides general information only and is not a guarantee of any coverage or reimbursement outcome. All treatment decisions rest solely with the treating physician or qualified healthcare professional. Jazz Pharmaceuticals reserves the right to terminate or modify this program at any time with or without notice. Other terms and conditions apply.
YOU ARE NOT ALONE
Connect with others who understand you or your loved one's journey with HER2-positive BTC.
Support and resources for patients and caregivers: personalized assistance and vital information to improve quality of life and treatment outcomes.
The Alliance raises awareness, provides education, and advocates to prevent, treat, and cure GI cancers.
CSC helps people impacted by cancer by providing support, fostering compassionate communities, and breaking down barriers to care.
The American Cancer Society is the leading cancer-fighting organization with a vision to end cancer as we know it, for everyone, through advocacy, research, and patient support.
FDA=Food and Drug Administration; GI=gastrointestinal; HER2=human epidermal growth factor receptor 2; IHC=immunohistochemistry.
